English
This article is from Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association , volume 18 . Abstract Background/Aim:: Adjuvant chemotherapy for 6 months is the current standard of care after potentially curative resection of pancreatic cancer and yields an overall survival of 15–20 months. Early tumor recurrence before or during adjuvant chemotherapy has not been evaluated so far. These patients may not benefit from adjuvant treatment. Patients and Methods:: Thirty-five patients with resection of ductal pancreatic carcinoma and adjuvant chemotherapy with gemcitabine were analyzed between 2005 and 2007. All patients had a computed tomography (CT) scan before and during adjuvant chemotherapy after 2–3 months, 12/35 patients had a histologically confirmed R1 resection. Recurrence of pancreatic cancer was determined by CT scan and the clinical course. Results:: Median survival of 35 patients with resected pancreatic cancer was 19.7 months, and the 2-year survival was 44%. Thirteen (37%) of the 35 patients analyzed with a CT scan showed tumor recurrence during adjuvant chemotherapy. Overall survival of patients with tumor recurrence was 9.3 months w
Sign in with your free account to read, download EPUBs or listen.
Ebook · Early Recurrence of Pancreatic Cancer after Resection and During Adjuvant Chemotherapy. · Fischer, Richard, Breidert, Matthias, Keck, Tobias, Makowiec, Frank, Lohrmann, Christian, Harder, Jan · Internet Archive